Pulse.

a daily field guide to health research that matters

◆ Console

‹ Thu · 29 Oct 2026
Standard addition

Omission of Radiation Therapy is Associated with Inferior Disease Control in High Risk Early-Stage Hodgkin Lymphoma

Adding radiation to chemotherapy improved disease control for bulky lymphomas, though survival remained similar and late side effects increased.

This retrospective multicenter propensity-matched cohort study examined Omission of Radiation Therapy is Associated with Inferior Disease Control in High Risk Early-Stage Hodgkin Lymphoma. Radiotherapy omission was associated with inferior disease control in bulky or interim-PET-positive disease, while overall survival was similar and late toxicity was more frequent with combined therapy.

What the study was

Study design
Retrospective multicenter propensity-matched cohort study
Population
Adults with stage I or II classical Hodgkin lymphoma
Sample size
810 patients; 480 propensity matched
Category
Treatment Innovation
Maturity
Validated
Journal
Blood advances

Why it surfaced

Retrospective multicenter propensity-matched cohort study; Radiotherapy omission was associated with inferior disease control in bulky or interim-PET-positive disease, while overall survival was similar and late toxicity was more frequent with combined therapy. Score kept conservative because only the PubMed abstract and metadata were reviewed.

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.